首页> 外国专利> Method for the Control System medicamentar adverse inflammatory and inflammatory Reactions and to produce compounds for the treatment of lapatologia adverse inflammatory reactions.

Method for the Control System medicamentar adverse inflammatory and inflammatory Reactions and to produce compounds for the treatment of lapatologia adverse inflammatory reactions.

机译:控制系统药物不良发炎和炎症反应的控制方法,以及制备用于治疗腹泻性不良发炎反应的化合物的方法。

摘要

Adverse inflammatory reactions can be treated by administering a Composition of an organism that has diglucosilamina as active ingredient.The preferred Compound is di - beta-d - glucopiranosilamina.Obtained a simple method to Fabricate a High purezamediante diglucosilamina in the reaction of glucose, a base containing Nitrogen, and either Methanol or ethanol to form the diglucosilamina,And then recovers ladiglucosilamina preferably with the use of Coal. The preferred diglucosilamina beta-d -, di - glucosilamina has an extraordinary actividadantiinflamatoria.Can be formulated with a pharmaceutically acceptable vehicle for making Pharmaceutical compositions that are effective in the treatment of inflammation.The pharmaceutical composition can also be used to treat adverse inflammatory reactions that are the result of alterations of a Dynamic Network of cellular mechanisms of losorgAnismos. In addition, the application of this composition also serves pararestablecer balance of network Defense cell in an organism's Defense Grid Cell unbalanced.In this case of imbalance, the composiciu00f3nsirve treating the pathology of inflammation and the Control System of active inflammation in vivo.These reactions inflamatoriasadversas may also be treated by Administering the body with glucose in the presence of ions of NH3, and at a pH of 7.0 u00f3mayor aproximdamente.Glucose can be applied preferably by oral administration of enteric coated form of glucose alone or INCOMBINATION with other medicines.
机译:可以通过给予以双葡糖胺作为活性成分的生物体的组合物来治疗不良炎症反应。优选的化合物为di-β-d-葡糖吡喃葡糖胺。获得了一种简单的方法来制备高纯度的中度双葡糖胺素含有氮,以及甲醇或乙醇,形成二葡糖基硅藻氨酸,然后优选使用煤回收Ladiglucosilamina。优选的二葡糖硅藻糖蛋白β-d-,二-葡糖硅藻糖蛋白具有非凡的活化抗炎作用。可以与药学上可接受的媒介物一起配制,以制备对炎症有效的药物组合物。该药物组合物还可以用于治疗不利的炎症反应,是losorgAnismos细胞机制动态网络变化的结果。此外,这种组合物的应用还可以在不平衡的生物体防御网格细胞中实现网络防御细胞的平衡,在这种不平衡的情况下,该复合物可以治疗炎症的病理学和体内活性炎症的控制系统。还可通过在NH3离子存在的条件下,在pH值为7.0的情况下向人体投与葡萄糖来治疗炎症反应型抗逆转录药。可通过口服口服肠溶衣形式的葡萄糖或与其他药物合用葡萄糖来优选使用葡萄糖。

著录项

  • 公开/公告号AR004353A1

    专利类型

  • 公开/公告日1998-11-04

    原文格式PDF

  • 申请/专利权人 BIODYNAMICS PHARMACEUTICALS INC.;

    申请/专利号AR1996P105401

  • 发明设计人

    申请日1996-11-28

  • 分类号A61K9/00;A61K31/13;C07H5/06;

  • 国家 AR

  • 入库时间 2022-08-22 02:58:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号